Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
125 hedge funds and large institutions have $410M invested in Flexion Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 43 reducing their positions, and 25 closing their positions.
106% more call options, than puts
Call options by funds: $3.06M | Put options by funds: $1.49M
3% less funds holding
Funds holding: 129 → 125 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
19% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 43
43% less capital invested
Capital invested by funds: $717M → $410M (-$307M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$19.6M |
| 2 |
AC
Armistice Capital
New York
|
+$6.27M |
| 3 |
CC
Carlson Capital
Dallas,
Texas
|
+$5.46M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.21M |
| 5 |
Goldman Sachs
New York
|
+$3.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$22.1M |
| 2 |
Bank of New York Mellon
New York
|
-$17.1M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$12.2M |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$7.76M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$7.33M |
FLXN Hedge Fund Activity: Q4 2018 in Review
125 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2018, worth a combined $410M — down 43% from $717M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of FLXN and 21 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 35 added.
The largest buyer was Morgan Stanley, adding an estimated $19.6M. The largest seller was Rubric Capital Management (New York), cutting an estimated $22.1M.
- 125 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2018, down from 129 in Q3 2018.
- Funds reported $410M of Flexion Therapeutics, Inc. stock for Q4 2018, down 43% quarter-over-quarter.
- 21 funds opened new Flexion Therapeutics, Inc. positions in Q4 2018 and 25 closed out, a net change of -4 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2018 was Morgan Stanley, an estimated $19.6M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2018 was Rubric Capital Management (New York), an estimated $22.1M sold.
Based on aggregated 13F filings for Q4 2018.